Vimkunya is now available in the US for the prevention of disease caused by chikungunya virus in individuals 12 years of age and older.
BOSTON, March 28, 2025 (GLOBE NEWSWIRE) -- HilleVax, Inc. (Nasdaq: HLVX), a clinical-stage biopharmaceutical company focused on developing and commercializing novel vaccines, today reported financial ...
4d
Pharmaceutical Technology on MSNValneva outlays 40,000 vaccines to Réunion amidst chikungunya surgeValneva will work with local health authorities and wholesalers on the French island territory to distribute the vaccines.
Intech Investment Management LLC acquired a new stake in shares of HilleVax, Inc. (NASDAQ:HLVX – Free Report) in the fourth quarter, according to the company in its most recent Form 13F filing with ...
The global animal vaccines market size was US$ 8.5 billion in 2021. The global animal vaccines market is forecast to grow to US$ 13.3 billion by 2030 by growing at a compound annual growth rate (CAGR) ...
December 31, 2024 The company is exploring the potential for continued development of its norovirus vaccine candidates in adults ...
A local Bucks County adult tested positive for measles after returning from a trip to Texas, health officials said.
The global animal vaccines market was valued at $9,093.9 million in 2020, and is projected to reach $13,780.6 million by 2028, registering a CAGR of 5.3% from 2021 to 2028. The market is expected to ...
Supporters say consumers should be protected from unknowingly eating material from novel vaccines, which are similar to COVID ...
Proof-of-Concept Study to Find Functional Cure for HIV July 24, 2024 — Researchers conducted a breakthrough proof-of-concept study that found an HIV-like virus particle that could cease the need ...
Low-cost, DIY air purifiers are proving to be just as effective as expensive commercial units at protecting indoor spaces ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results